Pfizer and BioNTech have launched a clinical trial for their Omicron specific COVID-19 vaccine on Tuesday. The study will evaluate the vaccine's safety in more than 1,400 participants. Amit N Thakker from the Africa Healthcare Federation has more on the impact of this clinical trial.
#Pfizer #Omicronvaccine #Africa
Subscribe: [ Ссылка ]
Livestream: [ Ссылка ]
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Visit our website: [ Ссылка ]
